|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for credit losses | |||||
| Depreciation | |||||
| Stock based compensation | |||||
| Amortization of intangible assets | |||||
| Gains on sales of other real estate owned, net | |||||
| Write-downs of other real estate owned | |||||
| Origination of loans held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Gains on sales of loans held for sale | |||||
| Losses on disposal of fixed assets, net | |||||
| Net accretion of investment securities discounts and premiums- AFS | |||||
| Net accretion of investment securities discounts and premiums- HTM | |||||
| Net gains on sales of investment securities - available-for-sale | |||||
| Amortization of deferred loan fees | |||||
| Deferred tax benefit | |||||
| Earnings on bank owned life insurance | |||||
| Amortization of operating lease right of use assets | |||||
| Amortization of operating lease liabilities | |||||
| (Increase)/decrease in accrued interest receivable and other assets | |||||
| Increase/(decrease) in accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Proceeds from maturities/calls of investment securities available-for-sale | |||||
| Proceeds from maturities/calls of investment securities held-to-maturity | |||||
| Proceeds from sales of investment securities available-for-sale | |||||
| Purchases of investment securities available-for-sale | |||||
| Purchases of investment securities held-to-maturity | |||||
| Purchases of equity securities with readily determinable fair market values | |||||
| Proceeds from sales of other real estate owned | |||||
| Proceeds from disposal of fixed assets | |||||
| Net decrease/(increase) in FHLB stock | |||||
| Net increase in loans | |||||
| Purchases of premises and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Net increase in deposits | |||||
| Proceeds from issuance of common stock | |||||
| Cash dividends paid on common stock | |||||
| Net (decrease)/increase in short-term borrowings | |||||
| Stock repurchase | |||||
| Proceeds from long-term borrowings | |||||
| Payments on long-term borrowings | |||||
| Net cash provided by financing activities | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental information | |||||
| Interest paid | |||||
| Taxes paid | |||||
| Non-cash investing activities: | |||||
| Transfers from loans to other repossessed assets | |||||
| Transfers from loans to other real estate owned | |||||
| Transfers from bank premises and equipment to other assets | |||||
Loading...